InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 13.27 CNY Market Closed
Market Cap: 11.2B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

InnoCare Pharma Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InnoCare Pharma Ltd
Interest Income Expense Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
InnoCare Pharma Ltd
SSE:688428
Interest Income Expense
-ÂĄ162.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Interest Income Expense
-ÂĄ59.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Interest Income Expense
ÂĄ217.7m
CAGR 3-Years
N/A
CAGR 5-Years
134%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Interest Income Expense
-ÂĄ8.1m
CAGR 3-Years
N/A
CAGR 5-Years
58%
CAGR 10-Years
9%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Interest Income Expense
-ÂĄ45.8m
CAGR 3-Years
27%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Interest Income Expense
ÂĄ78.6m
CAGR 3-Years
37%
CAGR 5-Years
99%
CAGR 10-Years
N/A

See Also

What is InnoCare Pharma Ltd's Interest Income Expense?
Interest Income Expense
-162.3m CNY

Based on the financial report for Dec 31, 2022, InnoCare Pharma Ltd's Interest Income Expense amounts to -162.3m CNY.

Back to Top